BTIG sees 'incremental positives' in Rezolute (RZLT) regulatory update
Tweet Send to a Friend
BTIG analyst Julian Harrison reiterated a Buy rating and $5.00 price target on Rezolute (NASDAQ: RZLT)The analyst commented, "The FDA ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


